Bayer
Pharmaceuticals
Germany
EU Taxonomy summary
38.7% of Bayer's revenues are EU Taxonomy eligible, with 0% also being Taxonomy aligned. 16.7% of Bayer's capital expenditures are EU Taxonomy eligible, with 0% also being Taxonomy aligned. Additionally, 2.5% of Bayer's operating expenses are EU Taxonomy eligible, with 0% also being Taxonomy aligned.
Bayer's revenues breakdown
Bayer's capital expenditures breakdown
Bayer's operating expenses breakdown
EU Taxonomy full disclosure
Revenues
FY2024 | Code | Value (EURm) | Proportion of total | CCM | CCA | WTR | PPC | CE | BIO | CCM DNSH | CCA DNSH | WTR DNSH | PPC DNSH | CE DNSH | BIO DNSH | Minimum safeguards | Previous year proportion | Category enabling activity | Category transitional activity | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover of environmentally sustainable activities (Taxonomy-aligned) (A.1) |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||||
Of which enabling |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||||
Of which transitional |
0 | 0% | 0% | 0% | ||||||||||||||||
1.2 = Manufacture of medicinal products |
PPC 1.2 | 18,047 | 38.7% | N/EL | N/EL | N/EL | EL | N/EL | N/EL | 38.4% | ||||||||||
Turnover of Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) (A.2) |
18,047 | 38.7% | 0% | 0% | 0% | 100% | 0% | 0% | 38.4% | |||||||||||
A. Turnover of Taxonomy eligible activities (A.1+A.2) |
18,047 | 38.7% | 0% | 0% | 0% | 100% | 0% | 0% | ||||||||||||
Turnover of Taxonomy-non-eligible activities |
28,559 | 61.3% | ||||||||||||||||||
Total (A+B) |
46,606 | 100% |
Show more...Show less...
Capital expenditures
FY2024 | Code | Value (EURm) | Proportion of total | CCM | CCA | WTR | PPC | CE | BIO | CCM DNSH | CCA DNSH | WTR DNSH | PPC DNSH | CE DNSH | BIO DNSH | Minimum safeguards | Previous year proportion | Category enabling activity | Category transitional activity | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CapEx of environmentally sustainable activities (Taxonomy-aligned) (A.1) |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||||
Of which enabling |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||||
Of which transitional |
0 | 0% | 0% | 0% | ||||||||||||||||
4.24 = Production of heat/cool from bioenergy |
CCM 4.24 | 12 | 0.4% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 0% | ||||||||||
5.1 = Construction, extension and operation of water collection, treatment and supply systems |
CCM 5.1 | 1 | 0% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 0% | ||||||||||
5.4 = Renewal of waste water collection and treatment |
CCM 5.4 | 0 | 0% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 0.1% | ||||||||||
6.5 = Transport by motorbikes, passenger cars and light commercial vehicles |
CCM 6.5 | 27 | 0.8% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 1% | ||||||||||
7.1 = Construction of new buildings |
CCM 7.1 | 76 | 2.3% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 0% | ||||||||||
7.2 = Renovation of existing buildings |
CCM 7.2 | 22 | 0.7% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 0.6% | ||||||||||
7.3 = Installation, maintenance and repair of energy efficiency equipment |
CCM 7.3 | 3 | 0.1% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 0% | ||||||||||
7.6 = Installation, maintenance and repair of renewable energy technologies |
CCM 7.6 | 1 | 0% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 0% | ||||||||||
7.7 = Acquisition and ownership of buildings |
CCM 7.7 | 0 | 0% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 0.5% | ||||||||||
1.2 = Manufacture of medicinal products |
PPC 1.2 | 407 | 12.4% | N/EL | N/EL | N/EL | EL | N/EL | N/EL | 14.1% | ||||||||||
CapEx of Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) (A.2) |
549 | 16.7% | 25.749% | 0% | 0% | 74.251% | 0% | 0% | ||||||||||||
A. CapEx of Taxonomy eligible activities (A.1+A.2) |
549 | 16.7% | 25.749% | 0% | 0% | 74.251% | 0% | 0% | ||||||||||||
CapEx of Taxonomy-non-eligible activities |
2,722 | 83.3% | ||||||||||||||||||
Total (A+B) |
3,271 | 100% |
Show more...Show less...
Operating expenses
FY2024 | Code | Value (EURm) | Proportion of total | CCM | CCA | WTR | PPC | CE | BIO | CCM DNSH | CCA DNSH | WTR DNSH | PPC DNSH | CE DNSH | BIO DNSH | Minimum safeguards | Previous year proportion | Category enabling activity | Category transitional activity | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OpEx of environmentally sustainable activities (Taxonomy-aligned) (A.1) |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||||
Of which enabling |
0 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |||||||||||
Of which transitional |
0 | 0% | 0% | 0% | ||||||||||||||||
1.2 = Manufacture of medicinal products |
PPC 1.2 | 176 | 2.5% | N/EL | N/EL | N/EL | EL | N/EL | N/EL | 2.2% | ||||||||||
OpEx of Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) (A.2) |
176 | 2.5% | 0% | 0% | 0% | 100% | 0% | 0% | 2.2% | |||||||||||
A. OpEx of Taxonomy eligible activities (A.1+A.2) |
176 | 2.5% | 0% | 0% | 0% | 100% | 0% | 0% | ||||||||||||
OpEx of Taxonomy-non-eligible activities |
7,000 | 97.5% | ||||||||||||||||||
Total (A+B) |
7,176 | 100% |
Show more...Show less...